Skip to content
Toggle navigation
Sign Up
Contact
Twitter
LinkedIn
Search
Search
About CARB-X
Overview
Global Threat
Our Strategy
Stewardship and Access
Management & Staff
Joint Oversight Board
Advisory Board
Careers
Annual Reports
Boston University
Portfolio
Portfolio Product Developers
Portfolio-Pipeline
CARB-X Graduates
Spotlight on Science
Portfolio Acceleration Tools
Partners
Funding Partners
Global Accelerator Network
Apply
2022-2023 Funding Themes
Omnibus Solicitation
Omnibus Outcomes
Entering Portfolio
Resources
CARB-X Connect
Presentations
Videos
Publications
Education
PD Resources
Fact Sheets
AMR Test Directory
News
CARB-X News
Recommended News
In the News
Antibiotic Resistance
Product Developer News
Events
About CARB-X
Overview
Global Threat
Our Strategy
Stewardship and Access
Management & Staff
Joint Oversight Board
Advisory Board
Careers
Annual Reports
Boston University
Portfolio
Portfolio Product Developers
Portfolio-Pipeline
CARB-X Graduates
Spotlight on Science
Portfolio Acceleration Tools
Partners
Funding Partners
Global Accelerator Network
Apply
Funding Themes
Omnibus Solicitation
Application Process (2022-2023)
Entering Portfolio
Applicant Questions (2019)
Resources
Presentations
Videos
Publications
Education
PD Resources
Fact Sheets
AMR Test Directory
News
CARB-X News
Recommended News
In the News
Antibiotic Resistance
Product Developer News
Events
Contact
Legal
News
Talis Biomedical Announces Pricing Of Initial Public Offering
Talis Biomedical Announces Pricing Of Initial Public Offering
Toggle navigation
Toggle navigation